Cancer research in an era when epigenetics is no longer "epi" -challenges and opportunitiescer

Chinese Journal of Cancer

Volumn 32, Issue 1, 2013, Pages 1-2

  Tao, Qian ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

CANCER RESEARCH; CPG ISLAND; DNA METHYLATION; EDITORIAL; EPIGENETICS; EXON; GENE MUTATION; GENE SEQUENCE; HUMAN; LANGUAGE; NEOPLASM; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN METHYLATION; TUMOR SUPPRESSOR GENE;

CPG ISLANDS; DNA METHYLATION; EPIGENOMICS; GENES, TUMOR SUPPRESSOR; GENOME; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84872194202     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.012.10300     Document Type: Editorial

References (7)

1. Jones PA, Baylin SB. The epigenomics of cancer. Cell, 2007,128:683-692.
2. Brandes JC, Carraway H, Herman JG. Optimal primer design using the novel primer design program: MSP primer provides accurate methylation analysis of the ATM promoter. Oncogene, 2007,26:6229-6237.
3. Tao Q, Swinnen L, Yang J, et al. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B-cell lymphoproliferative disease: application of PCR-based analysis. Am J Pathol, 1999,155:619-625.
4. Herman JG, Graff JR, Myönäen S, et al. Methylation-s pecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996,93:9821-9826.
5. Capel E, Fléjou JF, Hamelin R. Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis. Oncogene, 2007,26:7596-7600.
6. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer, 2006,6:107-116.
7. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature, 2012,490:61-70.